Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DFN-02 in Episodic Migraine
NCT02856802Phase 2Completed
- Sponsor
- Upsher-Smith Laboratories
- Start
- Jul 2016
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Zecuity in episodic migraine, sponsored by Upsher-Smith Laboratories. Started Jul 2016; status: completed.
02
Drugs
Zecuity
03
Conditions
episodic migraine
Beyond the preview
Go deeper on NCT02856802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02856802.